Incorporation of patients into assessment of drugs

The European Medicines Agency has organized a workshop supporting incorporation of patients into medicinal product assessment.

The European Medicines Agency (EMA) takes the view that not only the specialists, but even the patients should be given the opportunity to express their standpoint to evaluation and assessment of the medicinal products.
In autumn the EMA representatives met with the patients in a workshop and discussed further incorporation of patients, mainly into assessment of the risk/benefit ratio of the medicinal products.
EMA believes that opinions and points of view of the patients are very important and have to be considered.
Therefore during the workshop EMA has agreed the items with the patients which should support incorporation of the patients into evaluation and assessment.

If you are interested in what procedures will be pinpointed, you can read the whole article.


Register for receiving PharmaAround news, register for PharmAround events.
Continue registration